Skip to content

Clinical trials

Completed Phase 1 Obesity trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Obesity Phase: Phase 1 Status: Completed Clear all

441 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20022
20034
20044
200511
20069
200711
200821
200922
201022
201115
201214
201319
201419
20159
201622
20179
201820
201914
202025
202114
202223
202325
202453
202545
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed441

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S56
Eli Lilly and Company26
Pfizer18
AstraZeneca17
Amgen12
Mayo Clinic11
Boehringer Ingelheim10
BrightGene Bio-Medical Technology Co., Ltd.8
GlaxoSmithKline8
Vanderbilt University Medical Center5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Obesity441
Overweight150
Diabetes Mellitus, Type 253
Diabetes Mellitus23
Nutrition Disorders22
Weight Loss16
Insulin Resistance14
Non-alcoholic Fatty Liver Disease13
Metabolic Syndrome12
Cardiovascular Diseases11

Trials

Showing 1 to 25 of 441. Each trial links to its page on Pharma Observatory.

341 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.